Alzheimers

a53

ACETYLCHOLINESTERASE INHIBITORS

drugs that obstruct the capacity of the molecule acetyl cholinesterase to diminish the neurotransmitter acetylcholine in the synaptic cholinergic neurons.

AGE-APPROPRIATE MATURITY

emotional or mental readiness: the capacity to handle something very well and recover from well, with experience and to carry

ALZHEIMER'S DISEASE

introduced by a German psychologist, Alois Alzheimer, an advanced illness of the brain stemming from large amounts of destruction of

ALZHEIMER'S DISEASE AND RELATED DISORDERS AS

an enterprise that affords help and support teams, reinforcement, and suggestions for care providers of people with Alzheimer

ALZHEIMER'S FACILITIES

centers purposely structured to enhance the proper care of those with Alzheimer

AMYLOID PRECURSOR PROTEIN (APP)

a protein that, when severed by many enzymes, generates beta-amyloid. Build-up of beta-amyloid in the human brain is deemed to

APOLIPOPROTEIN E (APOE)

refers to a protein that may help break down beta-amyloid. Individuals carrying a ApoE4 allele, are statistically more likely to

BASAL FOREBRAIN

n. area of the brain responsible for memory, learning, and attention. Includes the cerebral cortex and hippocampus. When acetylcholine is

BETA-AMYLOID (P-AMYLOID)

n. a type of protein deposit found in the brain tissue of patients having Alzheimer's disease. This deposit contains peptides

BETA-SECRETASE (P-SECRETASE)

n. a protein enzyme (protease) which cleaves the amyloid precursor protein to form beta-amyloid. These are the peptides which build-up

BOSTON NAMING TEST (BNT)

n. a test in word retrieval designed for patients experiencing language disturbance such as those caused by dementia, stroke, and

BUTYRYLCHOLINESTERASE

n. a synthetic, non-specific cholinesterase enzyme identified in the liver and related tissues. It assists in regulating the level of